Haleigh Mistry

477 total citations
8 papers, 81 citations indexed

About

Haleigh Mistry is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Haleigh Mistry has authored 8 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 2 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Haleigh Mistry's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Haleigh Mistry is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Haleigh Mistry collaborates with scholars based in United States and United Kingdom. Haleigh Mistry's co-authors include Barbara Bannister, Stephen T. Chambers, William Weir, Christopher R. Flowers, Elizabeth J. Shpall, Paolo Strati, Sairah Ahmed, Jason R. Westin, Misha Hawkins and Raphaël Steiner and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Infection and Blood Advances.

In The Last Decade

Haleigh Mistry

7 papers receiving 78 citations

Peers

Haleigh Mistry
Tara M. Babu United States
Karen Lampe Germany
Said Jongo Tanzania
Paige Haas United States
Javier F. Morales United States
Ansu Bagchi United States
Xuequn Xu United States
Haleigh Mistry
Citations per year, relative to Haleigh Mistry Haleigh Mistry (= 1×) peers Michael N. T. Souter

Countries citing papers authored by Haleigh Mistry

Since Specialization
Citations

This map shows the geographic impact of Haleigh Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haleigh Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haleigh Mistry more than expected).

Fields of papers citing papers by Haleigh Mistry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haleigh Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haleigh Mistry. The network helps show where Haleigh Mistry may publish in the future.

Co-authorship network of co-authors of Haleigh Mistry

This figure shows the co-authorship network connecting the top 25 collaborators of Haleigh Mistry. A scholar is included among the top collaborators of Haleigh Mistry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haleigh Mistry. Haleigh Mistry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kurtin, Sandra, et al.. (2022). Biomarker Jeopardy. Journal of the Advanced Practitioner in Oncology. 13(3). 292–297.
2.
Feng, Lei, Grace Watson, Sairah Ahmed, et al.. (2022). Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy. Blood Advances. 6(9). 2867–2871. 26 indexed citations
3.
Strati, Paolo, Fateeha Furqan, Jason R. Westin, et al.. (2020). Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).. Journal of Clinical Oncology. 38(15_suppl). 8011–8011. 11 indexed citations
4.
Mistry, Haleigh, et al.. (2019). Immune-Mediated Therapies in Lymphoma. Seminars in Oncology Nursing. 35(5). 150925–150925. 1 indexed citations
5.
Mistry, Haleigh, et al.. (2018). Managing Cancer Survivorship Issues. The Journal for Nurse Practitioners. 14(4). 337–343. 2 indexed citations
6.
Mistry, Haleigh, et al.. (2017). Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm. Clinical journal of oncology nursing. 21(2). 53–59. 4 indexed citations
7.
Mistry, Haleigh, et al.. (2013). Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and Ribavirin. International Journal of STD & AIDS. 24(3). 179–183. 11 indexed citations
8.
Weir, William, et al.. (1984). Chronic Q fever associated with granulomatous hepatitis. Journal of Infection. 8(1). 56–60. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026